FDA Releases Final Guidance on Reducing Sepsis-Related Infections in Human Cells, Tissues, and Products

Summary

The FDA has issued a final guidance to help establishments reduce the risk of sepsis-related infections in human cells, tissues, and products, in response to a public health safety concern and to address the urgent need for updated recommendations in donor eligibility determinations.